Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Email this article to a friend

Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective

Jean-Louis Vincent email, Rolf Rossaint, Bruno Riou, Yves Ozier, David Zideman and Donat R Spahn

Critical Care 2006, 10:R120doi:10.1186/cc5026

Your name*
Your email address*
Recipient's email address*
(multiple email addresses should be separated with commas)
Email format
Please type your message into the box below:
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.